Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) EBIT Margin (2010 - 2026)

Updated

Vistagen Therapeutics' EBIT Margin was -7925.36% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 152.88 percentage points from -7772.48% a year earlier and down 7021.03 percentage points from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) EBIT Margin (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vistagen Therapeutics' EBIT Margin was -2541.90% through Sep 30, 2026, up 6538.82 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -5683.69%, up 5833.39 percentage points from FY2025.

  • EBIT Margin shows a five-year change of -4037.63 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, EBIT Margin was -11517.08% in FY2025 (-8413.60 pp), -3103.48% in FY2024 (+23005.77 pp), -26109.25% in FY2023 (-21800.96 pp) and -4308.30% in FY2022 (-2662.24 pp).
  • The fiscal Q2 2027 figure marks the lowest quarterly EBIT Margin since fiscal Q1 2025.
  • Compared with a year earlier, EBIT Margin was higher in four of the last six quarters, with an average year-over-year change of +1475.62 percentage points.
  • The best year-over-year quarter for EBIT Margin over five years was fiscal Q4 2023 (a gain of 35848.59 percentage points); the worst was fiscal Q4 2022 (a drop of 41395.55 percentage points).
  • Per Business Quant data, VTGN's EBIT Margin in the three fiscal quarters before Q2 2027 was -904.34% (Q1 2027), -3595.05% (Q4 2026) and -6450.83% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -907.40%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 34.46%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 24.35%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 36.01%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 30.74%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 41.71%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -7,925.36%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -7,925.36%
Jun 30, 2026 -904.34%
Mar 31, 2026 -3,595.05%
Dec 31, 2025 -6,450.83%
Sep 30, 2025 -7,772.48%
Jun 30, 2025 -6,477.05%
Dec 31, 2024 -6,461.54%
Sep 30, 2024 -7,774.32%
Jun 30, 2024 -14,441.67%
Mar 31, 2024 -6,926.22%
Dec 31, 2023 -1,918.25%
Sep 30, 2023 -2,260.00%
Jun 30, 2023 -3,499.00%
Mar 31, 2023 -6,953.98%
Dec 31, 2022 -5,425.83%
Sep 30, 2022 -1,958.49%
Jun 30, 2022 -6,376.36%
Mar 31, 2022 -42,802.56%
Dec 31, 2021 -2,943.85%
Sep 30, 2021 -3,575.42%
API Access

Vistagen Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEY